Biological Characterization of Trypanosoma cruzi Strains

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 1, 2001, Pages 53-59

  Martínez Díaz, Rafael A ^a   Escario, José A ^b   Nogal Ruiz, Juan J ^b   Gómez Barrio, Alicia ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Characterization; Strains; Trypanosoma cruzi

Indexed keywords

CRYSTAL VIOLET; NIFURTIMOX; NITROIMIDAZOLE DERIVATIVE;

ANIMAL; ARTICLE; CERCOPITHECUS; CHAGAS DISEASE; DRUG EFFECT; DRUG SENSITIVITY; GENETIC VARIABILITY; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIFE CYCLE; MACROPHAGE; MOUSE; PARASITOLOGY; POPULATION GENETICS; TRYPANOSOMA CRUZI; VERO CELL;

ANIMALS; CERCOPITHECUS AETHIOPS; CHAGAS DISEASE; GENETICS, POPULATION; GENTIAN VIOLET; LIFE CYCLE STAGES; MACROPHAGES; MICE; NIFURTIMOX; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; TRYPANOSOMA CRUZI; VARIATION (GENETICS); VERO CELLS;

EID: 0041411673     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000100006     Document Type: Article

References (45)

1. Allaoui A, François C, Zemzoumi K, Guilvard E, Ouaissi A 1999. Intracellular growth and metacyclogenesis defects in Trypanosma cruzi carrying a targeted deletion of a TC52 protein-encodin allele. Mol Microbiol 32: 1273-1286.
2. Andrade SG, Figueira RM 1977. Estudo experimental sobre açào terapêutica da droga Ro 7-1051 na infecçào por diferentes cepas do Trypanosoma cruzi. Rev Inst Med Trop Sào Paulo 19: 335-341.
3. Andrade SG, Figueira RM, Carvalho ML, Gorini DF 1975. Influência da cepa do Trypanosoma cruzi na reposta à terapêutica experimental pelo Bay 2502. Rev Inst Med Trop Sào Paulo 17: 330-339.
4. Andrade SG, Magalhàes JB, Pontes, AL 1985. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull WHO 63: 721-726.
5. Atienza J 1994. Cribado farmacológico contra Trypanosoma (Schizotrypanum) cruzi Chagas, 1909, PhD, Thesis, Universidad Complutense de Madrid, 436 pp.
6. Barbosa W, Czerewuta AC, Barbosa CA, Olivera OS 1988. Nota sobre a variaçào do comportamento da patogenicidade e imunogenicidade de cepas de Trypanosoma cruzi variedade hastatus e Y mutante após longo periode de manutençào em cultura. Rev Patol Trop 17: 1-8.
7. Brener Z 1980. Immunity to Trypanosoma cruzi. Adv Parasitol 18: 247-292.
8. Brener Z, Chiari E 1967. Susceptibilidades de diferentes amostras de Trypanosoma cruzi a vários agentes quimioterápicos. Rev Inst Med Trop Sào Paulo 9: 197-207.
9. Brener Z, Costa CA, Chiari E 1976. Differences in the susceptibility of Trypanosoma cruzi to active chemotherapeutic agents. Rev Inst Med Trop Sào Paulo 11: 245-249.
10. Carreǹo H, Rojas C, Aguilera X, Apt N, Miles MA, Solari A 1987. Schizodeme analysis of Trypanosoma cruzi zymodemes from Chile. Exp Parasitol 64: 252-260.
11. De Castro SL, De Meirelles MN 1987. Effect of drugs on Trypanosoma cruzi and on its interaction with heart muscle cell "in vitro". Mem Inst Oswaldo Cruz 82: 209-218.
12. Fernandez-Gomez R, Esteban S, Gomez-Corvera R, Kherrouche Z, Ouaissi A 1998. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J Immunol 160: 3471-3479.
13. Filardi SL, Brener Z 1984. A rapid method for testing "in vivo" the susceptibility of different strains of Trypanosoma cruzi to active of chemotherapeutic agents. Mem Inst Oswaldo Cruz 79: 221-225.
14. Filardi LS, Brener Z 1990. Results of specific treatment with benznidazole in mice at the acute and chronic phase of Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 85: 99.
15. Funayama GK, Prado Junior JC 1974. Estudo sobre os caracteres de una amostra boliviana do Trypanosoma cruzi . Rev Soc Bras Med Trop 8: 75-81.
16. Grace TDC 1962. Establishment of four strains of cells from insect tissue growth in vitro. Nature 195: 788-789.
17. Habekorn A, Gonert R 1972. Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi. Arznein Forsch 22: 1570-1581.
18. Herrero A, Ochoa C, Atienza A, Escario JA, Gómez Barrio A, Martinez Fernandez AR 1992. Synthesis and antiprotozoal properties of 1,2,6-thiadiazine 1,1-dioxide derivates. Arch Pharm (Weinheim) 325: 504-514.
19. Kagan IG, Norman L, Allain D 1966. Studies on Trypanosoma cruzi isolated in the United States: a review. Rev Biol Trop 14: 55-73.
20. Ley V, Andrews NW, Robbins ES, Nussenzweig NW 1988. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med 168: 649-659.
21. McCabe RE, Remington JS, Araujo F 1984. Mechanisms of invasion and replication of the intracellular stage in Trypanosoma cruzi. Infect Inmunol 46: 372-376.
22. Melo RC, Brener Z 1978. Tissue tropism of different Trypanosoma cruzi strains. J Parasitol 64: 475-482.
23. Miles MA, Lanham SM, Souza AA, Póvoa M 1980. Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification. Trans R Soc Trop Med Hyg, 74: 221-237.
24. Miles MA, Souza A, Povoa M, Shaw JJ, Lainson R, Toye P 1978. Isoenzymic heterogeneity of Trypanosoma cruzi in the first autochtonous patients with Chagas' disease in Amazonian Brazil. Nature 272: 819-821.
25. Montamat EE, Durand S, Bocco JL, De Luca D'Oro GM, Blanco A 1999. Identification of Trypanosoma cruzi zymodemes by kinetoplast DNA probes. J Euk Microbiol 46: 155-159.
26. Morel CM, Chiari E, Plessman Camargo E, Matte, DM, Romanha AJ, Simpson L 1980. Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proe Natl Acad Sci USA 77: 6810-6814.
27. Neal RA, Van Bueren J 1988. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi "in vivo" and "in vitro". Trans R Soc Trop Med Hyg 82: 709-714.
28. Osuna Carrillo A, Jimenez Ortiz A, Lozano Maldonado J 1979. Medios de cultivo para la obtención de formas metacíclicas de Trypanosoma cruzi. Rev Ibér Parasitol 39: 129-133.
29. Ouaissi A, Dubremetz JF, Sehoneck R, Fernandez-Gomez R, Gomez-Corvera R, Billaut-Mulot O, Taibi A, Loyens M, Tartar A, Sergheraert C, Kusnierz JP 1995a. Trypanosoma cruzi: a 52-kDa protein sharing homology with glutatione S -transferase is localized in parasite organelles morphologically resembling reservosomes. Exp Parasitol 81: 453-461.
30. Ouaissi A, Guevara-Espinoza A, Chabé F, Fernandez-Gomez R, Taibi A 1995b. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces unresponsiveness of T cells through specific interaction with cysteine and glutathione. Immunol Lett 48: 221-224.
31. Prado Junior JC, Ribeiro RD, Albuquerque S, Carraro AA, Lopes RA, Garcia TAR, Toldo MA 1992a. Infecçào natural do Gato do Mato, Felis yagouaroundi, pelo Trypanosoma cruzi. 14o Encontro de Pesquisas Veterinárias (UNESP), p. 247.
32. Prado Junior JC, Ribeiro RD, Albuquerque S, Carraro AA, Lopes RA, García MAR 1992b. Natural infection of Guara, Chrysocyon brachyurus, by Trypanosoma cruzi. 14o Encontro de Pesquisas Veterinárias (UNESP), p. 246.
33. Ready PD, Miles MA 1980. Delimination of Trypanosoma cruzi zymodemes by numerical taxonomy. Trans R Soc Trop Med Hyg 74: 238-242.
34. Ribeiro RD, Albuquerque S, Carraro AA, Lopes RA, Prado Junior JC, García TAR, Toldo MPA 1993. Uma nova cepa do Trypanosoma cruzi isolada do triatomineo Triatoma infestans. 45o Reuniào da SBPC, p. 769.
35. Ribeiro RD, Albuquerque S, Carraro TA, Rissato TA 1988. Índice de cura de camundongos tratados coin nifurtimox e benzonidazol na doença de Chagas experimental. Rev Cien Farm S Paulo 10: 71-76.
36. Roval LE, Aoki A, Gerez de Burgos NM, Blanco A 1990. Effect of Gossypol on trypomastigotes and amastigotes of Trypanosoma cruzi. J Protozool 37: 280-286.
37. Schenkman S, Andrews NW, Nussenzweig W, Robbins ES 1988. Trypanosoma cruzi invade a mammalian epithelial cell in a polarized manner. Cell 55: 157-165.
38. Silva LH, Nussenzweig V 1953. Sobre uma cepa de Trypanosoma cruzi virulenta para o camundongo branco. Folia Clin Biol 20: 191-207.
39. Solari A, Muñoz S, Venegas J, Wallace A, Aguilera X, Apt W, Brèniere SF, Tibayrenc M 1992. Characterization of Chilean, Bolivian and Argentinian Trypanosoma cruzi populations by restriction endonuclease and isozyme analysis. Exp Parasitol 75: 187-195.
40. Steindel M, Dias Neto E, De Menezes CLP, Romanha AJ, Simpson AJG 1993. Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains. Mol Biochem Parasitol 60: 71-80.
41. Tibayrenc M, Ayala F 1987. Forte correlation entre classification isoenzymatique et variabilité de l' ADN kinetoplastique chez Trypanosoma cruzi. Comp Rend S Acad Sci Paris 304: 89-92.
42. Tibayrenc M, Ayala F 1988. Isoenzyme variability in Trypanosoma cruzi, the agent of Chagas' disease: genetical, taxonomic and epidemiological significance. Evolution 42: 277-292.
43. Tibayrenc M, Ward P, Moya A, Ayala F 1986 Natural populations of Trypanosoma cruzi, the agent of Chagas' disease, have a complex multiclonal structure. Proc Natl Acad Sci USA 83: 115-119.
44. Toledo MJO, Pereira MES, Brener Z 1990. Effects of immunosupression on the specific treatment of mice experimentally infected with Trypanosoma cruzi. Mem Inst Oswaldo Cruz 85: 100.
45. WHO 1991. Control of Chagas' disease. WHO Technical Report, Series No. 811, Geneva.